BRENIPATIDE
UNII C3939LZT6J

Substance Identification & Data

This profile provides standardized clinical and technical data for Brenipatide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) C3939LZT6J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2408921-49-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
C3939LZT6J
CAS Registry Number
2408921-49-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BRENIPATIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C223275
National Cancer Institute reference terminology for clinical and research data.
INN ID
14009
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
NO-106
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Brenipatide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BRENIPATIDE

Common Names & Synonyms

BRENIPATIDE [INN]
BRENIPATIDE [USAN]
D -TYROSYL-2-METHYLALANYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L -.ALPHA.-ASPARTYL-L-TYROSYL-L-SERYL-L-ISOLEUCYL-2-METHYL-L-LEUCYL-L-LEUCYL-L-.ALPHA.-ASPARTYL-L -LYSYL-N6-((22S)-22,42-DICARBOXY-10,19,24-TRIOXO-3,6,12,15-TETRAOXA-9,18,23-TRIAZADOTETRACONTAN-1-OYL)- L -LYSYL-L-ALANYL-L-GLUTAMINYL-2-METHYLALANYL-L-.ALPHA.-GLUTAMYL-L-PHENYLALANYL-L-ISOLEUCYL- L-.ALPHA.-GLUTAMYL-.ALPHA.-METHYL-L-TYROSYL-L-LEUCYL-L-ISOLEUCYL-L-ALANYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-ALANYL-L-PROLYL- L-PROLYL-L-PROLYL-L-SERINAMIDE GASTRIC INHIBITORY POLYPEPTIDE (GIP) AND GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONIST
D-TYROSYL-2-METHYLALANYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-TYROSYL-L-SERYL-L-ISOLEUCYL-2-METHYL-L-LEUCYL-L-LEUCYL-L-.ALPHA.-ASPARTYL-L-LYSYL-N6-(N-(19-CARBOXY-1-OXONONADECYL) -L-.GAMMA.-GLUTAMYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL) -L-LYSYL-L-ALANYL-L-GLUTAMINYL-2-METHYLALANYL-L-.ALPHA.-GLUTAMYL-L-PHENYLALANYL-L-ISOLEUCYL-L-.ALPHA.-GLUTAMYL-.ALPHA.-METHYL-L-TYROSYL-L-LEUCYL-L-ISOLEUCYL-L-ALANYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-ALANYL-L-PROLYL-L-PROLYL-L-PROLYL-L-SERINAMIDE
L-SERINAMIDE, D-TYROSYL-2-METHYLALANYL-L-.ALPHA.-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-.ALPHA.-ASPARTYL-L-TYROSYL-L-SERYL-L-ISOLEUCYL-2-METHYL-L-LEUCYL-L-LEUCYL-L-.ALPHA.-ASPARTYL-L-LYSYL-N6-(N-(19-CARBOXY-1-OXONONADECYL)-L-.GAMMA.-GLUTAMYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL)-L-LYSYL-L-ALANYL-L-GLUTAMINYL-2-METHYLALANYL-L-.ALPHA.-GLUTAMYL-L-PHENYLALANYL-L-ISOLEUCYL-L-.ALPHA.-GLUTAMYL-.ALPHA.-METHYL-L-TYROSYL-L-LEUCYL-L-ISOLEUCYL-L-ALANYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-ALANYL-L-PROLYL-L-PROLYL-L-PROLYL-

Technical Codes

LY3537031
LY-3537031

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus